Semaglutide
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Novo Nordisk · Phase 3 · Status n/r · Enrollment 370
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.